AQUIPTA® (Atogepant) ABBVIE HK Reg. No. HK-68287 (03 Jul, 2024) & HK-68288 (03 Jul, 2024) Composition: 1 Aquipta® (Atogepant) is an orally administered, small molecule, selective calcitonin gene-related peptide (CGRP) receptor antagonist...

LEQEMBI® (lecanemab) EISAI HK Reg. No. HK-68289 (03 Jul, 2024) & HK-68290 (03 Jul, 2024) Composition: 3 LEQEMBI® is an amyloid beta-directed antibody with the active ingredient lecanemab-irmb. It is administered as an intravenous infusio...

Vyepti ® ( Eptinezumab ) 6-7 Lundbeck Eptinezumab is a recombinant humanized monoclonal antibody that selectively inhibits calcitonin generelated peptide (CGRP) Compositio n : Available as a 100 mg/1mL concentrated solution for infusion Indica...